BACKGROUND: Due to its short duration of therapy and low rates of local recurrence, women undergoing breast conservation are increasingly opting for partial breast irradiation with the MammoSite (Cytyc/Hologic) catheter. In early follow-up studies, few complications were reported. Few data, however, exist regarding longer-term complications. We compared the long-term local toxicities of MammoSite partial breast irradiation with those resulting from whole breast radiation. STUDY DESIGN: This was a retrospective study performed in a single academic medical center. All patients who underwent breast-conserving surgery between 2003 and 2008, who met institutional criteria for brachytherapy, were included. We compared women treated with MammoSite with patients treated with whole breast radiation therapy (WBRT). Endpoints included incidence of palpable masses at the lumpectomy site, telangiectasias, and local recurrence. RESULTS: Seventy-one MammoSite patients and 245 WBRT patients were well matched with regard to clinical characteristics. Median follow-up was 4 years. A palpable mass developed at the site of lumpectomy in 27% of the MammoSite patients compared with 7% of the WBRT patients (p < 0.0001). Telangiectasias developed more frequently in the MammoSite group than in the WBRT group (24% vs 4%, p < 0.001). Forty-two percent of patients treated with MammoSite developed a palpable mass, telangectasia, or both. CONCLUSIONS: Palpable masses and telangiectasias are frequent long-term complications after MammoSite brachytherapy and occur at a significantly higher rate after MammoSite brachytherapy than after WBRT. This increased rate of long-term local toxicity should be considered when counseling women on options for adjuvant radiation therapy after breast-conserving surgery.
BACKGROUND: Due to its short duration of therapy and low rates of local recurrence, women undergoing breast conservation are increasingly opting for partial breast irradiation with the MammoSite (Cytyc/Hologic) catheter. In early follow-up studies, few complications were reported. Few data, however, exist regarding longer-term complications. We compared the long-term local toxicities of MammoSite partial breast irradiation with those resulting from whole breast radiation. STUDY DESIGN: This was a retrospective study performed in a single academic medical center. All patients who underwent breast-conserving surgery between 2003 and 2008, who met institutional criteria for brachytherapy, were included. We compared women treated with MammoSite with patients treated with whole breast radiation therapy (WBRT). Endpoints included incidence of palpable masses at the lumpectomy site, telangiectasias, and local recurrence. RESULTS: Seventy-one MammoSitepatients and 245 WBRT patients were well matched with regard to clinical characteristics. Median follow-up was 4 years. A palpable mass developed at the site of lumpectomy in 27% of the MammoSitepatients compared with 7% of the WBRT patients (p < 0.0001). Telangiectasias developed more frequently in the MammoSite group than in the WBRT group (24% vs 4%, p < 0.001). Forty-two percent of patients treated with MammoSite developed a palpable mass, telangectasia, or both. CONCLUSIONS: Palpable masses and telangiectasias are frequent long-term complications after MammoSite brachytherapy and occur at a significantly higher rate after MammoSite brachytherapy than after WBRT. This increased rate of long-term local toxicity should be considered when counseling women on options for adjuvant radiation therapy after breast-conserving surgery.
Authors: M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Pamela R Benitez; Martin E Keisch; Frank Vicini; Alan Stolier; Troy Scroggins; Alonzo Walker; Julia White; Peter Hedberg; Mary Hebert; Doug Arthur; Vic Zannis; Coral Quiet; Oscar Streeter; Mel Silverstein Journal: Am J Surg Date: 2007-10 Impact factor: 2.565
Authors: K Kenneth Chao; Frank A Vicini; Michelle Wallace; Christina Mitchell; Peter Chen; Michel Ghilezan; Samuel Gilbert; Jonathan Kunzman; Pamela Benitez; Alvaro Martinez Journal: Int J Radiat Oncol Biol Phys Date: 2007-04-30 Impact factor: 7.038
Authors: Martin Keisch; Frank Vicini; Robert R Kuske; Mary Hebert; Julia White; Coral Quiet; Doug Arthur; Troy Scroggins; Oscar Streeter Journal: Int J Radiat Oncol Biol Phys Date: 2003-02-01 Impact factor: 7.038
Authors: Alexandra J Stewart; Desmond A O'Farrell; Robert A Cormack; Jorgen L Hansen; Atif J Khan; Subhakar Mutyala; Phillip M Devlin Journal: Radiat Oncol Date: 2008-11-19 Impact factor: 3.481
Authors: William Small; Tamer Refaat; Jonathan B Strauss; Mahesh Gopalakrishnan; Kevin P Bethke; Ellen B Mendelson; Judith A Wolfman; Borko D Jovanovic; Krystyna Kiel Journal: J Radiat Oncol Date: 2015-11-02